Latest filing published 22 Jun 2021 for Spectrum Pharmaceuticals INC.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Bernice R. Welles: trading record in brief
Bernice R. Welles, listed as board member, appears in our data through filings on Spectrum Pharmaceuticals Inc shares, published by SEC (Form 4). The record holds 4 filings, for trades running from 18 June 2018 to 17 June 2021.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 22 June 2021, reports a share grant in Spectrum Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Bernice R. Welles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 14,277 shares0Common Stock, $0.001 par valueSEC:0001209191-21-042486:0
1 of 1 declaration